MGX
Metagenomi Therapeutics Inc (MGX) Investor Questions
Review Metagenomi Therapeutics Inc (MGX) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Metagenomi Therapeutics Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 39
- Annual revenue
- $25.21M
- Annual net income
- $-87.87M
- Annual free cash flow
- $-89.47M
Metagenomi Therapeutics Inc (MGX) Investor Questions research
Metagenomi Therapeutics Inc trades under the ticker MGX. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review MGX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.